Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2025-12-24 @ 5:19 PM
NCT ID: NCT03748550
Eligibility Criteria: Inclusion Criteria: * 1\) must be 18 years or older. * diagnosed with breast cancer (stages I-III) and not have started therapy. * must be scheduled to receive AC- based chemotherapy (minimum dose of 240 mg/m2 of DOX or 300 mg/m2 of DAN). * are able to undertake a 12-week home-based, progressive aerobic exercise program. * have medical clearance from a cardiologist (e.g. based on stress test results) to participate in the study. Exclusion Criteria: * significant cognitive limitations. * pre-existing medical condition that would otherwise contraindicate aerobic exercise.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Study: NCT03748550
Study Brief:
Protocol Section: NCT03748550